This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
MicroVision (MVIS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
MicroVision (MVIS) closed the most recent trading day at $2.36, moving -1.67% from the previous trading session.
Implied Volatility Surging for MicroVision (MVIS) Stock Options
by Zacks Equity Research
Investors need to pay close attention to MicroVision (MVIS) stock based on the movements in the options market lately.
Implied Volatility Surging for MicroVision (MVIS) Stock Options
by Zacks Equity Research
Investors need to pay close attention to MicroVision (MVIS) stock based on the movements in the options market lately.
MicroVision (MVIS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
MicroVision (MVIS) closed the most recent trading day at $2.02, moving -0.98% from the previous trading session.
Is Microvision (MVIS) Stock Outpacing Its Computer and Technology Peers This Year?
by Zacks Equity Research
Is (MVIS) Outperforming Other Computer and Technology Stocks This Year?
Microvision (MVIS) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Microvision's (MVIS) Q2 performance is likely to have been impacted by the COVID-19 induced fall in consumer demand. However, it is likely to have benefited from its robust portfolio of IPs.
The Zacks Analyst Blog Highlights: Workhorse Group, Veritone, Microvision, Energy Focus and Wayfair
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Workhorse Group, Veritone, Microvision, Energy Focus and Wayfair
Wall Street Sees Best Quarter After 1998: 5 Top Winners
by Tirthankar Chakraborty
Recovering from a drop of 20% in Q1, the broader S&P 500 rallied around 20% in Q2, the biggest quarterly gain in more than two decades.
The Zacks Analyst Blog Highlights: Microvision, Veritone, Remark, Novavax and DCP
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Microvision, Veritone, Remark, Novavax and DCP
Wall Street Readies for Best Quarter Ever: 5 Picks
by Tirthankar Chakraborty
The S&P 500 is up 21.2% so far in Q2 and is on pace for its biggest quarterly gain since Q1 of 1975. Similarly, the Nasdaq is up 31.6% since the end of Q1, putting it on pace for its second-best quarter ever.
The Zacks Analyst Blog Highlights: Aileron Therapeutics, Energy Focus, MicroVision, Mersana Therapeutics and CymaBay Therapeutics
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Aileron Therapeutics, Energy Focus, MicroVision, Mersana Therapeutics and CymaBay Therapeutics
5 Top Stocks Up 100%+ in May With More Room to Run
by Tirthankar Chakraborty
Reopening of the economy, vaccine hopes and stimulus measures helped Wall Street climb north in May and squash the old adage "sell in May and go away."
Best Stocks From the Top Sectors of an Upbeat May
by Sweta Killa
While all the sectors gained last month, information technology, materials, communications services, industrials and consumer discretionary were the toppers.
MicroVision (MVIS) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
by Zacks Equity Research
MicroVision (MVIS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MicroVision Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
MicroVision has been struggling lately, but the selling pressure may be coming to an end soon.
MicroVision, Inc. (MVIS) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in MicroVision, Inc. (MVIS).
MicroVision (MVIS) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
MicroVision (MVIS) delivered earnings and revenue surprises of 16.67% and -6.67%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
MicroVision (MVIS) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
MicroVision (MVIS) delivered earnings and revenue surprises of 0.00% and -73.62%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Laser Systems & Components Industry Outlook: Prospects Dull
by Aniruddha Ganguly
The Zacks Laser Systems and Components industry participants are negatively impacted by a slowing China market and tariffs imposed on imports from China.
Will MicroVision (MVIS) Report Negative Q4 Earnings? What You Should Know
by Zacks Equity Research
MicroVision (MVIS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IPG Photonics (IPGP) in Focus: Stock Moves 7.2% Higher
by Zacks Equity Research
IPG Photonics (IPGP) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
Laser Systems and Components Industry Outlook: Prospects Dim
by Zacks Equity Research
The Zacks Laser Systems and Components industry participants are negatively impacted by a slowing China market and tariff imposed on imports from China.
Do Options Traders Know Something About MicroVision (MVIS) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to MicroVision (MVIS) stock based on the movements in the options market lately.
MicroVision (MVIS) Reports Break-Even Earnings for Q3
by Zacks Equity Research
MicroVision (MVIS) delivered earnings and revenue surprises of 100.00% and -15.84%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Are Options Traders Betting on a Big Move in MicroVision (MVIS) Stock?
by Zacks Equity Research
Investors need to pay close attention to MicroVision (MVIS) stock based on the movements in the options market lately.